Clinical Trial: Tislelizumab Combined With XELOX as Perioperative Therapy for Locally Advanced Gastric Cancer
Study Status: Active, not recruiting
Recruit Status: Active, not recruiting
Condition: Locally Advanced Gastric Adenocarcinoma
Study Type: Interventional
Official Title: Tislelizumab Combined With XELOX as Perioperative Therapy for Locally Advanced Gastric Cancer: A Single-center, Single-arm, Phase ? Study
Brief Summary:
The effective treatment of locally advanced gastric cancer has always been a research hotspot in academia. In recent years, mainstream studies have shown that the treatment mode of locally advanced gastric cancer has changed from single surgery mode in the past, to multi-disciplinary comprehensive treatment mode for now, which is based on surgery. Several studies indicate that for most late-stage LAGC, the perioperative treatment model can further enhance the survival rates and prognosis of patients, compared with…
Read more